SPP1 and metabolic dysfunction-associated steatohepatitis: Moreover, intrahepatic OPN signaling by CREBZFOPN stimulates the activation of HSCs and fibrogenic cells and induces liver fibrosis and inflammation, worsening NASH severity [50].